WST
West Pharmaceutical Services Inc
363.30$
-0.9%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 30.8% | 32.7% | 17.0% | 23.5% | 24.1% | 25.4% | 18.5% | 23.1% | 24.5% | 31.2% | 10.6% | 14.2% | 19.9% | |
| 4.8% | 4.9% | 5.1% | 5.5% | 5.4% | 5.4% | 5.6% | 5.3% | 5.3% | 5.8% | 5.3% | 5.3% | 5.4% | |
| 0.8% | 0.2% | 0.7% | 0.6% | 0.7% | 0.6% | 0.2% | 1.0% | 1.0% | 0.8% | 0.8% | 1.2% | 1.0% | |
| 1.1% | – | – | – | – | – | – | – | – | – | – | – | – | |
| 3.3% | 3.7% | -5.0% | 2.0% | 0.0% | 3.1% | 0.0% | 0.0% | 0.3% | 7.9% | -12.2% | 11.8% | 2.0% | |
| 12.8% | 14.8% | 13.0% | 14.3% | 10.9% | 14.0% | 10.2% | 9.8% | 7.9% | 9.5% | 5.1% | 5.0% | 6.8% | |
| -34.8% | -14.9% | -13.0% | -14.4% | -11.0% | -14.0% | -10.2% | -9.8% | -7.9% | -9.5% | -5.1% | -5.0% | -6.8% | |
| 1.9% | 2.0% | 2.1% | 2.1% | 1.9% | 2.0% | 2.2% | 2.0% | 1.9% | 2.0% | 1.9% | 1.8% | 1.9% | |
| -3.8% | -24.2% | -39.2% | -26.7% | -7.0% | -7.3% | -19.5% | -0.1% | 0.0% | 0.0% | -35.2% | 34.1% | 0.0% | |
| -0.1% | – | – | – | -0.5% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| -3.0% | -25.9% | -39.0% | -31.1% | -8.6% | -9.2% | -21.1% | -1.9% | -1.4% | -1.5% | -36.5% | -18.9% | -14.9% | |
| -75.7% | -6.1% | -36.3% | -22.2% | 6.0% | -0.8% | -11.5% | 13.8% | 14.8% | 20.2% | -31.9% | -9.8% | -2.2% | |
| 18.0% | 17.8% | 4.0% | 9.2% | 13.2% | 11.4% | 8.3% | 13.3% | 16.6% | 21.7% | 5.6% | 9.3% | 13.1% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.